Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease.
J Hepatol. 2021 Sep;75(3):623-633. doi: 10.1016/j.jhep.2021.04.033. Epub 2021 May 6.
J Hepatol. 2021.
PMID: 33964370
Free article.